: We assessed the impact of the 2023/2024 COVID-19 vaccination campaign in Italy by estimating the number of averted COVID-19 severe cases (i.e. COVID-19 associated hospitalisations or deaths) between October 2023 and March 2024, in those aged ≥60 years. We estimated that 565 (95 % CI: 497-625) cases, corresponding to 2.1 % (95 % CI: 1.8-2.3) of the expected cases without a vaccination campaign, were averted. We simulated three vaccination coverage scenarios: 50 %, 75 %, 90 % (versus the observed 10.7 %), finding that 9.7 % (95 % CI: 8.5-10.7); 14.5 % (95 % CI: 12.8-16.1); and 17.4 % (95 % CI: 15.3-19.3) of the expected cases would have been averted, respectively.

Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023–March 2024) / Fotakis, E. A.; Picasso, E.; Sacco, C.; Petrone, D.; Del Manso, M.; Bella, A.; Riccardo, F.; Odone, A.; Cannone, A.; Tallon, M.; De Angelis, L.; Sciurti, A.; Cescutti, D.; Pezzotti, P.; Fabiani, M.; Mateo-Urdiales, A.. - In: VACCINE. - ISSN 0264-410X. - 42:26(2024). [10.1016/j.vaccine.2024.126375]

Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023–March 2024)

Sacco, C.;Petrone, D.;Del Manso, M.;Riccardo, F.;Cannone, A.;De Angelis, L.;Sciurti, A.;Fabiani, M.;
2024

Abstract

: We assessed the impact of the 2023/2024 COVID-19 vaccination campaign in Italy by estimating the number of averted COVID-19 severe cases (i.e. COVID-19 associated hospitalisations or deaths) between October 2023 and March 2024, in those aged ≥60 years. We estimated that 565 (95 % CI: 497-625) cases, corresponding to 2.1 % (95 % CI: 1.8-2.3) of the expected cases without a vaccination campaign, were averted. We simulated three vaccination coverage scenarios: 50 %, 75 %, 90 % (versus the observed 10.7 %), finding that 9.7 % (95 % CI: 8.5-10.7); 14.5 % (95 % CI: 12.8-16.1); and 17.4 % (95 % CI: 15.3-19.3) of the expected cases would have been averted, respectively.
2024
COVID-19; Elderly population; Monovalent XBB-adapted vaccines; SARS-CoV-2; Vaccination impact
01 Pubblicazione su rivista::01a Articolo in rivista
Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023–March 2024) / Fotakis, E. A.; Picasso, E.; Sacco, C.; Petrone, D.; Del Manso, M.; Bella, A.; Riccardo, F.; Odone, A.; Cannone, A.; Tallon, M.; De Angelis, L.; Sciurti, A.; Cescutti, D.; Pezzotti, P.; Fabiani, M.; Mateo-Urdiales, A.. - In: VACCINE. - ISSN 0264-410X. - 42:26(2024). [10.1016/j.vaccine.2024.126375]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1719859
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact